Conatus Pharmaceuticals (NASDAQ:CNAT) Stock Rating Upgraded by ValuEngine

Retrieved on: 2020-01-26 11:56:15

Tags for this article:

Click the tags to see associated articles and topics

Conatus Pharmaceuticals (NASDAQ:CNAT) Stock Rating Upgraded by ValuEngine. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC raised its stake in shares of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) by 90.7% in the second quarter, ...</div>

Article found on:

View Original Article